Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

10 Items

per page
  1. AT13387
    A4056 AT13387
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; ≥13.25 mg/mL
  2. AUY922 (NVP-AUY922)
    A4057 AUY922 (NVP-AUY922)
     1 Citation
    Target: HSP90
    Summary: Potent Hsp90 inhibitor
      ≥23.27 mg/mL
  3. IPI-504 (Retaspimycin hydrochloride)
    A4061 IPI-504 (Retaspimycin hydrochloride)
     3 Citation
    Target: HSP90
    Summary: Hsp90 inhibitor,novel, potent,selective
      ≥26.1 mg/mL
  4. NVP-BEP800
    A4064 NVP-BEP800
    Target: HSP90
    Summary: Oral Hsp90β inhibitor, novel, fully synthetic
  5. PF-04929113 (SNX-5422)
    A4065 PF-04929113 (SNX-5422)
    Target: HSP90
    Summary: Hsp90 inhibitor,potent and selective
      ≥23.85 mg/mL
  6. XL-888
    A4388 XL-888
     1 Citation
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.2 mg/mL
  7. Gedunin
    B7393 Gedunin
    Target: HSP90
    Summary: naturally occurring Hsp90 inhibitor
      Soluble in DMSO
  8. HSP990 (NVP-HSP990)
    B4797 HSP990 (NVP-HSP990)
    Target: HSP90
    Summary: Hsp90 inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥12.3 mg/mL
  9. EC 144
    B4920 EC 144
    Target: HSP90
    Summary: High affinity, potent and selective Hsp90 inhibitor
      <41.39 mg/mL
  10. 17-DMAG (Alvespimycin) HCl
    A2213 17-DMAG (Alvespimycin) HCl
     1 Citation
    Target: HSP90
    Summary: Hsp90 inhibitor
      ≥26.2 mg/mL

10 Items

per page